Jo A. Van Ginderachter
机构:Vrije Universiteit Brussel, VIB-VUB Laboratory Myeloid Cell Immunology · ORCID:0000-0002-4442-7474
发表论文 264 篇 · 总被引 23661 次 · h-index 63
代表论文
- Nanobodies targeting the tumor microenvironment and their formulation as nanomedicines (2025 · Molecular Cancer · 被引 70)
- Phase I Study of [68Ga]Ga-Anti-CD206-sdAb for PET/CT Assessment of Protumorigenic Macrophage Presence in Solid Tumors (MMR Phase I) (2023 · Journal of Nuclear Medicine · 被引 53)
- Current status and future expectations of nanobodies in oncology trials (2023 · Expert Opinion on Investigational Drugs · 被引 43)
- Preclinical Evaluation of a Radiotheranostic Single-Domain Antibody Against Fibroblast Activation Protein α (2023 · Journal of Nuclear Medicine · 被引 36)
- Lipocalin-2: A Nurturer of Tumor Progression and a Novel Candidate for Targeted Cancer Therapy (2023 · Cancers · 被引 32)
- Imaging of tumor-associated macrophage dynamics during immunotherapy using a CD163-specific nanobody-based immunotracer (2024 · Proceedings of the National Academy of Sciences · 被引 30)